HNSCC is characterized by dysregulation of the autophagy–lysosome pathway, specifically the p62/SQSTM1 protein and overexpression of fibronectin 1 (FN1), which has been associated with poorer prognosis and higher tumor pathological grade in HNSCC patients. The gene discussed is FN1; the disease is neoplasm.